These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2211702

  • 1. The selective inhibition of thrombin by peptides of boroarginine.
    Kettner C, Mersinger L, Knabb R.
    J Biol Chem; 1990 Oct 25; 265(30):18289-97. PubMed ID: 2211702
    [Abstract] [Full Text] [Related]

  • 2. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A, Mennecier P, Lila C, de Nanteuil G, Verbeuren TJ.
    Thromb Haemost; 1997 Oct 25; 78(4):1221-7. PubMed ID: 9364988
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New inhibitors of thrombin and other trypsin-like proteases: hydrogen bonding of an aromatic cyano group with a backbone amide of the P1 binding site replaces binding of a basic side chain.
    Lee SL, Alexander RS, Smallwood A, Trievel R, Mersinger L, Weber PC, Kettner C.
    Biochemistry; 1997 Oct 28; 36(43):13180-6. PubMed ID: 9341205
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitor.
    Tapparelli C, Metternich R, Ehrhardt C, Zurini M, Claeson G, Scully MF, Stone SR.
    J Biol Chem; 1993 Mar 05; 268(7):4734-41. PubMed ID: 8444849
    [Abstract] [Full Text] [Related]

  • 8. Kinetic and crystallographic studies of thrombin with Ac-(D)Phe-Pro-boroArg-OH and its lysine, amidine, homolysine, and ornithine analogs.
    Weber PC, Lee SL, Lewandowski FA, Schadt MC, Chang CW, Kettner CA.
    Biochemistry; 1995 Mar 21; 34(11):3750-7. PubMed ID: 7893672
    [Abstract] [Full Text] [Related]

  • 9. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ, Almond HR, Hecker LR, Schott MR, Yabut SC, Zhang HC, Andrade-Gordon P, Corcoran TW, Giardino EC, Kauffman JA, Lewis JM, de Garavilla L, Haertlein BJ, Maryanoff BE.
    J Med Chem; 2005 Mar 24; 48(6):1984-2008. PubMed ID: 15771442
    [Abstract] [Full Text] [Related]

  • 10. Anticoagulant activity of a peptide boronic acid thrombin inhibitor by various routes of administration in rats.
    Hussain MA, Knabb R, Aungst BJ, Kettner C.
    Peptides; 1991 Mar 24; 12(5):1153-4. PubMed ID: 1800952
    [Abstract] [Full Text] [Related]

  • 11. Characterization of a class of peptide boronates with neutral P1 side chains as highly selective inhibitors of thrombin.
    Deadman JJ, Elgendy S, Goodwin CA, Green D, Baban JA, Patel G, Skordalakes E, Chino N, Claeson G, Kakkar VV.
    J Med Chem; 1995 Apr 28; 38(9):1511-22. PubMed ID: 7739010
    [Abstract] [Full Text] [Related]

  • 12. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ, Weng D, Chesebro JH, Fuster V, Badimon L.
    Thromb Haemost; 1994 Apr 28; 71(4):511-6. PubMed ID: 8052972
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
    Wienand A, Ehrhardt C, Metternich R, Tapparelli C.
    Bioorg Med Chem; 1999 Jul 28; 7(7):1295-307. PubMed ID: 10465405
    [Abstract] [Full Text] [Related]

  • 14. Effect of thrombin inhibitors on platelet functions: comparative analysis of DuP 714 and hirudin.
    Reilly TM, Knabb RM, Hassell SM, Bozarth JM, Forsythe MS, Mayo MC, Racanelli AL, Mousa SA.
    Blood Coagul Fibrinolysis; 1992 Oct 28; 3(5):513-7. PubMed ID: 1450317
    [Abstract] [Full Text] [Related]

  • 15. Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems.
    Kaiser B, Callas D, Hoppensteadt D, Mallinowska K, Fareed J.
    Thromb Res; 1994 Mar 01; 73(5):327-35. PubMed ID: 8016817
    [Abstract] [Full Text] [Related]

  • 16. Dose-effect relationship for several coagulation markers during administration of the direct thrombin inhibitor S 18326 in healthy subjects.
    Gaussem P, Dubar M, le Bonniec B, Richard-Lordereau I, Jochemsen R, Aiach M.
    Br J Clin Pharmacol; 2002 Feb 01; 53(2):147-54. PubMed ID: 11851638
    [Abstract] [Full Text] [Related]

  • 17. Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation.
    Wachtfogel YT, Hack CE, Nuijens JH, Kettner C, Reilly TM, Knabb RM, Bischoff R, Tschesche H, Wenzel H, Kucich U.
    Am J Physiol; 1995 Mar 01; 268(3 Pt 2):H1352-7. PubMed ID: 7535008
    [Abstract] [Full Text] [Related]

  • 18. Highly selective tripeptide thrombin inhibitors.
    Shuman RT, Rothenberger RB, Campbell CS, Smith GF, Gifford-Moore DS, Gesellchen PD.
    J Med Chem; 1993 Feb 05; 36(3):314-9. PubMed ID: 8426361
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids.
    Kettner CA, Shenvi AB.
    J Biol Chem; 1984 Dec 25; 259(24):15106-14. PubMed ID: 6392293
    [Abstract] [Full Text] [Related]

  • 20. Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and D-Phe-Pro-Arg-Ch2Cl.
    Yang XJ, Blajchman MA, Craven S, Smith LM, Anvari N, Ofosu FA.
    Biochem J; 1990 Dec 01; 272(2):399-406. PubMed ID: 2268268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.